
Rakovina Therapeutics appoints Oishi as CEO, director
Rakovina Therapeutics appoints Oishi as CEO, director

Rakovina Therapeutics appoints Oishi as CEO, director
Hydreight closes $15-million bought deal
Premier Health Reports 2025 Fourth Quarter Results
Mindbio will analyze your voice, detect intoxication
Rocket Doctor AI signs contract with U.S. insurer
Innocan Pharma Corporation Anticipates Listing on the NYSE American Stock Exchange with Concurrent Offering
Rakovina Therapeutics Announces Corporate Update Including up to $1.5 Million in New Financing, Leadership Appointments and Debt Restructuring
Hydreight Technologies Inc. Announces Closing of Oversubscribed $15 Million Bought Deal LIFE Offering
MindBio Targets Global Digital Health Diagnostics Market with World First AI Powered Speech Analytics Technology
Rocket Doctor Signs New Contract with Major U.S. Insurer, Expanding Access to an Additional 175,000 Members Across California
BriaCell Highlights Extended >18-47 Months Survival in Phase 2 Metastatic Breast Cancer Patients
SEEGNAL PRESENTS REAL-WORLD EVIDENCE ON REDUCING FALL RISK IN GERIATRIC PATIENTS AT CALTCM SUMMIT
Comprehensive Healthcare Systems Upsizes Non-Brokered Private Placement
Neupath Health appoints Lemieux as CEO
Bionxt moves cladribine ODF to clinic